CompletedInterventionalPhase 2Updated Mar 14, 2022
Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome（Diarrhea Type） | NCT00948870 | Trialant
CompletedInterventionalNot ApplicableUpdated Mar 7, 2013
Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome（Diarrhea Type）
ClinicalTrials.gov ID
NCT00948870
Lead Sponsor
Shanghai University of Traditional Chinese MedicineOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
200Actual
Last Update Posted
Mar 7, 2013Estimated
Start Date
Aug 2009
Primary Completion Date
Jul 2011Actual
Completion Date
Sep 2011Actual
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Shugan decoction on irritable bowel syndrome（diarrhea type）.
Irritable Bowel Syndrome
Traditional Chinese Medicine
Shugan decoction
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of irritable bowel syndrome（diarrhea type）
Male of female patients between 18-65 years old
Written informed consent
Exclusion Criteria:
Discrepancy of irritable bowel syndrome
Diarrhea-type of irritable bowel syndrome combine with intestinal disease
Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
Pregnancy or breast feeding women, or unwilling to have contraception.
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
Longhua hospital
Shanghai, Shanghai Municipality, China
Lead Sponsor
Shanghai University of Traditional Chinese MedicineOTHER